Pulse nav.journalClub Debates activos Tendencias Explorar Preguntas Investigadores

Download the App

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

© Synapse Social LLC, 2026

Política de privacidad

Inicio Explorar nav.journalClub Tendencias

⌘+K

Tirzepatide for Weight Reduction in Chinese Adults With Obesity | Synapse

May 31, 2024Open Access

Tirzepatide for Weight Reduction in Chinese Adults With Obesity

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Obesity has become a global public health concern and China has the largest number of affected people worldwide.

Leer artículo completoexternamente

Me gusta

Guardar

Compartir

Ver artículo completo

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Zhao et al. (Fri,) studied this question.

synapsesocial.com/papers/68e67617b6db6435875fff3e https://doi.org/https://doi.org/10.1001/jama.2024.9217

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Obesity and cardiovascular disease: revisiting an old relationship2018 · 716 citations
2Untitled2022 · 1 citations
3Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults--study on optimal cut-off points of body mass index and waist circumference in Chinese adults.2002 · 1,611 citations
4Occurrence of nausea, vomiting and diarrhoea reported as adverse events in clinical trials studying glucagon‐like peptide‐1 receptor agonists: A systematic analysis of published clinical trials2016 · 359 citations
5LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept2018 · 824 citations